{"nct_id":"NCT00657683","title":"A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age","status":"COMPLETED","status_verified_date":"2011-12","start_date":"2007-12","start_date_type":null,"primary_completion_date":"2009-04","primary_completion_date_type":"ACTUAL","completion_date":"2009-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}